Sep 25 |
Nuwellis to Present at the Third Annual ROTH Healthcare Opportunities Conference
|
Aug 27 |
New Study Published in Current Problems in Cardiology Highlights Statistically Significant Reduction in Heart Failure Readmissions at 60 days when using the Aquadex Ultrafiltration Therapy
|
Aug 23 |
Nuwellis to sell 496,901 shares at $1.845 in registered direct offering
|
Aug 23 |
Nuwellis Announces Pricing of $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
|
Aug 13 |
Nuwellis, Inc. (NUWE) Q2 2024 Earnings Call Transcript
|
Aug 13 |
Nuwellis GAAP EPS of -$18.85 misses by $10.61, revenue of $2.19M beats by $0.19M
|
Aug 13 |
Nuwellis, Inc. Announces Second Quarter 2024 Financial Results
|
Aug 12 |
Nuwellis Q2 Earnings Preview
|
Aug 8 |
Nasdaq Panel Grants Nuwellis Continued Listing on the Nasdaq Stock Market, Subject to Conditions
|
Jul 29 |
Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
|